These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 21864076)
1. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions. Shahrizaila N; Yuki N Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review. Kaida K; Kusunoki S J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612 [TBL] [Abstract][Full Text] [Related]
3. [Antiganglioside antibodies: when, which and for what]. Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234 [TBL] [Abstract][Full Text] [Related]
6. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies]. Kaida K Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466 [TBL] [Abstract][Full Text] [Related]
11. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies]. Kusunoki S Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820 [TBL] [Abstract][Full Text] [Related]
12. The immunobiology of Guillain-Barré syndromes. Willison HJ J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123 [TBL] [Abstract][Full Text] [Related]
13. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism. Yuki N; Uncini A Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718 [TBL] [Abstract][Full Text] [Related]
15. New concepts of Guillain-Barré syndrome. Asbury AK J Child Neurol; 2000 Mar; 15(3):183-91. PubMed ID: 10757475 [TBL] [Abstract][Full Text] [Related]
16. GQ1b antibody testing in Guillain-Barre syndrome and variants. Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410 [TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis. Yuki N Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987 [TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies. Prendergast MM; Moran AP J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055 [TBL] [Abstract][Full Text] [Related]
19. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study. Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183 [TBL] [Abstract][Full Text] [Related]